Institute of Data
  • Learn Practical AI Skills
  • Find Jobs
  • Career Consultation
  • Job Alerts
  • Post a Job
  • Employers
  • Sign in
  • Sign up
  • Learn Practical AI Skills
  • Find Jobs
  • Career Consultation
  • Job Alerts
  • Post a Job
  • Employers

717 director early clinical development jobs found

Refine Search
Current Search
director early clinical development
Refine by Specialisation
Management  (177) Engineering - Software  (62) Programme & Project Management  (49) Product Management & Development  (45) Developers & Programmers  (41) Consultants  (25)
Architects  (22) Business & Systems Analyst  (21) Help Desk & IT Support  (16) Security  (4) Other  (1) Testing & Quality Assurance  (1)
More
Refine by Job Type
Full time  (293) Part time  (23) Internship  (16) Contract  (4)
Refine by State
New York  (99) Massachusetts  (79) Illinois  (58) Colorado  (46) Pennsylvania  (39) Ohio  (37)
Minnesota  (34) Connecticut  (26) Michigan  (24) Tennessee  (21) Iowa  (20) Indiana  (18) Wisconsin  (17) Oklahoma  (16) Missouri  (15) South Carolina  (15) Alaska  (13) Hawaii  (11) Kansas  (11) New Mexico  (11)
More
Refine by Country
United States  (708) Canada  (3) United Kingdom  (2) United states  (2) New Zealand  (1) US  (1)
Refine by City
New York  (57) Boston  (39) Chicago  (37) Denver  (35) Columbus  (15) Saint Paul  (15)
Des Moines  (14) Hartford  (14) Indianapolis  (14) Columbia  (13) Cambridge  (12) Honolulu  (11) Juneau  (11) Madison  (11) Albany  (10) Harrisburg  (10) Lansing  (10) Minneapolis  (10) Oklahoma City  (10) Providence  (10)
More
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Columbus, OH, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 14, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Montpelier, VT, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Providence, RI, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Harrisburg, PA, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Denver, CO, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Boston, MA, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Topeka, KS, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Juneau, AK, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Santa Fe, NM, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Springfield, IL, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Lansing, MI, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Concord, NH, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Madison, WI, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Saint Paul, MN, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Bismarck, ND, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Columbia, SC, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Nashville, TN, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Hartford, CT, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Honolulu, HI, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Lincoln, NE, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Augusta, ME, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Frankfort, KY, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Oklahoma City, OK, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
Otsuka Pharmaceutical Companies (U.S.)
Director, Early Clinical Development - CNS
Otsuka Pharmaceutical Companies (U.S.) Cheyenne, WY, USA
The Director will lead activities related to Early Clinical Development (ECD) essential to the growth of Otsuka's discovery and early phase pipeline within OPDC's Early Development Organization (EDO). Reporting to the ECD CNS Therapeutic Area Head, this Director is a strategic scientific and clinical leader accountable for the end-to-end early clinical development strategy and execution for Otsuka's early phase portfolio, with emphasis on CNS, particularly psychiatry, neurodegenerative disease, and neuroinflammation. The role shapes program strategy from indication selection through early clinical development (pre-IND through first-in-human and clinical proof of concept) and go/go no decisions based on clinical and/or biomarker driven endpoints ensuring seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions. The Director, ECD - CNS, in alignment with the ECD therapeutic area head and functional head VP, collaborates with...

Feb 13, 2026
  • Home
  • Learn Practical AI Skills
  • Contact
  • About Us
  • Terms & Conditions
  • Industry Training
  • United States
  • Australia
  • Singapore
  • New Zealand
  • Industry Jobs
  • Find Jobs
  • Create Resume
  • Sign in
  • Career Consultation
  • Facebook
  • LinkedIn
© Institute of Data. All rights reserved.